Daming City announced on the evening of June 22 that the company's controlling subsidiary, Kangsheng Investment, passed the Tibet Kangsheng Dingzeng No. 1 and subscribed for the non-public offering of the shares and Yuyue Medical . It is worth noting that just a few days ago, Kangsheng Investment just became the largest shareholder of Boxin by successively increasing its holdings.
It is understood that this time, Tibet Kangsheng Dingzeng No. 1 subscribed for 4.373 million shares of non-public offering of shares, accounting for 1.30% of the total number of shares after the issuance of the shares. Tibet Kangsheng Dingzeng No. 1 subscribed for the 842,400 shares of Yuyue Medical's non-public offering, accounting for 1.26% of the total number of shares after the release of Yuyue Medical. According to the content of the announcement, Tibet Kangsheng Dingzeng No. 1 participated in the joint share and Yuyue Medical's non-public offering of shares required to use funds of 418 million yuan.
Kangsheng Investment is an important securities investment platform of Daming City. As early as September 2, 2015, Kangsheng Investment completed the placard against Ananda and is still the second largest shareholder of Ananda. On September 11, 2015, Kangsheng Investment completed the first placard of Boxin shares. On June 18, 2016, Kangsheng Investment continued to increase its holding of 423,300 shares of Boxin. After the increase, Kangsheng Investment held a total of 34.932 million shares of Boxin shares, accounting for 15.18% of the total shares of Boxin, becoming the largest shareholder of Boxin shareholders. .
It is worth noting that on May 10 this year, Daming City also became the object of being placarded. The placard is the related person who solves the problem of the actual controller.
On April 26, 2016, Daming City announced that it plans to acquire the medium-term lease of Zhongzhi System in cash of 2.5 billion yuan. The relationship between Daming City and Nakajima does not seem to be very simple.
Some market analysts believe that after the company has become an important shareholder of Daming City, it is not excluded that the two parties will join hands to develop more cooperation in the securities market. In the future, it will not rule out the possibility of Da Ming City increasing its investment in securities.
VTM sampling kits are designed for the collection, preservation, and transport of viruses, chlamydia, mycoplasma, and ureaplasma urea. They are now widely used for sampling and transporting prior to virus detection. MandeLab's VTM kits provide a safe and convenient way to collect and transport virus samples.
Nasal swab kit virus sampling tube,Used to collect samples of secretions from the throat or nasal cavity, Disposable
Jiangsu iiLO Biotechnology Co., Ltd. , https://www.iilogene.com